Passage Bio

PASG · NASDAQ

$3.60+$0.02 (+0.56%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $3.58

Latest news

Press releaseJul 23, 1:41 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG
NewsJun 25, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
Press releaseJun 24, 4:05 PM ETGlobe Newswire
Passage Bio and Remix Therapeutics Announce Merger Agreement
NewsApr 20, 2:15 PM ETAvi Kapoor
Crude Oil Surges Over 6%; Investar Holding Shares Gain Following Q1 Earnings
NewsApr 20, 1:05 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
NewsApr 20, 10:08 AM ETAvi Kapoor
US Stocks Mixed; Cleveland-Cliffs Shares Fall After Q1 Results
NewsApr 20, 9:10 AM ET
Reported Earlier: Passage Bio Receives FDA Guidance Requiring Randomized Registrational Trial For PBFT02 in FTD-GRN, Evaluates Next Steps In Clinical Development
Press releaseApr 20, 7:00 AM ETGlobe Newswire
Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates
NewsApr 10, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsApr 1, 8:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseMar 3, 7:00 AM ETGlobe Newswire
Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights
Press releaseNov 10, 4:15 PM ETGlobe Newswire
Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights
Press releaseNov 5, 7:00 AM ETGlobe Newswire
Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference
Press releaseOct 14, 7:00 AM ETGlobe Newswire
Passage Bio to Participate in Chardan's 9th Annual Genetic Medicines Conference
Press releaseAug 28, 7:00 AM ETGlobe Newswire
Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference
NewsAug 12, 8:08 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press releaseAug 12, 7:00 AM ETGlobe Newswire
Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights
NewsJul 25, 1:07 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsJul 10, 8:09 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseJul 10, 7:00 AM ETGlobe Newswire
Passage Bio Announces 1-for-20 Reverse Stock Split
NewsJun 26, 8:08 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsJun 23, 7:07 AM ET
Passage Bio Reports Interim Data From upliFT-D Showing Durable CSF PGRN Elevation And Reduced Plasma NfL Versus Natural History In FTD-GRN
Press releaseJun 23, 7:00 AM ETGlobe Newswire
Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update
Press releaseMay 13, 7:00 AM ETGlobe Newswire
Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights
NewsMay 12, 5:06 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsMar 13, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseNov 13, 7:00 AM ETGlobe Newswire
Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
NewsOct 25, 8:07 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG

12 Health Care Stocks Moving In Thursday's Intraday Session

Passage Bio and Remix Therapeutics Announce Merger Agreement

Crude Oil Surges Over 6%; Investar Holding Shares Gain Following Q1 Earnings

12 Health Care Stocks Moving In Monday's Intraday Session

US Stocks Mixed; Cleveland-Cliffs Shares Fall After Q1 Results

Reported Earlier: Passage Bio Receives FDA Guidance Requiring Randomized Registrational Trial For PBFT02 in FTD-GRN, Evaluates Next Steps In Clinical Development

Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights

Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights

Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Passage Bio to Participate in Chardan's 9th Annual Genetic Medicines Conference

Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Passage Bio Announces 1-for-20 Reverse Stock Split

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Passage Bio Reports Interim Data From upliFT-D Showing Durable CSF PGRN Elevation And Reduced Plasma NfL Versus Natural History In FTD-GRN

Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update

Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights

12 Health Care Stocks Moving In Friday's Pre-Market Session